Literature DB >> 23377561

Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease.

Shonit Punwani1, King Kenneth Cheung, Nicholas Skipper, Nichola Bell, Alan Bainbridge, Stuart A Taylor, Ashley M Groves, Sharon F Hain, Simona Ben-Haim, Ananth Shankar, Stephen Daw, Steve Halligan, Paul D Humphries.   

Abstract

BACKGROUND: Accurate assessment of splenic disease is important for staging Hodgkin lymphoma.
OBJECTIVE: The purpose of this study was to assess T2-weighted imaging with and without dynamic contrast-enhanced (DCE) MRI for evaluation of splenic Hodgkin disease.
MATERIALS AND METHODS: Thirty-one children with Hodgkin lymphoma underwent whole-body T2-weighted MRI with supplementary DCE splenic imaging, and whole-body PET-CT before and following chemotherapy. Two experienced nuclear medicine physicians derived a PET-CT reference standard for splenic disease, augmented by follow-up imaging. Unaware of the PET-CT, two experienced radiologists independently evaluated MRI exercising a locked sequential read paradigm (T2-weighted then DCE review) and recorded the presence/absence of splenic disease at each stage. Performance of each radiologist was determined prior to and following review of DCE-MRI. Incorrect MRI findings were ascribed to reader (lesion present on MRI but missed by reader) or technical (lesion not present on MRI) error.
RESULTS: Seven children had splenic disease. Sensitivity/specificity of both radiologists for the detection of splenic involvement using T2-weighted images alone was 57%/100% and increased to 100%/100% with DCE-MRI. There were three instances of technical error on T2-weighted imaging; all lesions were visible on DCE-MRI.
CONCLUSIONS: T2-weighted imaging when complemented by DCE-MRI imaging may improve evaluation of Hodgkin disease splenic involvement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377561     DOI: 10.1007/s00247-012-2616-7

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  27 in total

1.  Dynamic gadolinium-enhanced MR imaging of the spleen: normal enhancement patterns and evaluation of splenic lesions.

Authors:  S A Mirowitz; J J Brown; J K Lee; J P Heiken
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

2.  Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.

Authors:  Henriëtte M E Quarles van Ufford; Thomas C Kwee; Frederik J Beek; Maarten S van Leeuwen; Taro Takahara; Rob Fijnheer; Rutger A J Nievelstein; John M H de Klerk
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

Review 3.  MR imaging of the spleen: spectrum of abnormalities.

Authors:  Khaled M Elsayes; Vamsidhar R Narra; Govind Mukundan; James S Lewis; Christine O Menias; Jay P Heiken
Journal:  Radiographics       Date:  2005 Jul-Aug       Impact factor: 5.333

4.  Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging.

Authors:  B R Hoane; A F Shields; B A Porter; J W Borrow
Journal:  Am J Hematol       Date:  1994-10       Impact factor: 10.047

5.  Dynamic contrast-enhanced magnetic resonance imaging in a model of splenic metastasis.

Authors:  V M Runge; N M Williams
Journal:  Invest Radiol       Date:  1998-01       Impact factor: 6.016

6.  Solitary lymphangioma of the spleen: dynamic MR findings with pathological correlation.

Authors:  W-C Chang; C-H Liou; H-W Kao; C-C Hsu; C-Y Chen; C-Y Yu
Journal:  Br J Radiol       Date:  2007-01       Impact factor: 3.039

Review 7.  Fast STIR whole-body MR imaging in children.

Authors:  Christian J Kellenberger; Monica Epelman; Stephen F Miller; Paul S Babyn
Journal:  Radiographics       Date:  2004 Sep-Oct       Impact factor: 5.333

Review 8.  Lymphoma of the spleen.

Authors:  Kunwar Bhatia; Anju Sahdev; Rodney H Reznek
Journal:  Semin Ultrasound CT MR       Date:  2007-02       Impact factor: 1.875

9.  Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.

Authors:  Bingsheng Huang; Martin Wai-Ming Law; Pek-Lan Khong
Journal:  Radiology       Date:  2009-02-27       Impact factor: 11.105

10.  Toward complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  Acad Radiol       Date:  2003-06       Impact factor: 3.173

View more
  9 in total

1.  Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Authors:  R Syha; L Grünwald; T Horger; D Spira; D Ketelsen; W Vogel; C D Claussen; M Horger
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

2.  Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey.

Authors:  Domenico Albano; Alessandro Stecco; Giuseppe Micci; Luca Maria Sconfienza; Stefano Colagrande; Alfonso Reginelli; Roberto Grassi; Alessandro Carriero; Massimo Midiri; Roberto Lagalla; Massimo Galia
Journal:  Radiol Med       Date:  2020-06-22       Impact factor: 3.469

3.  Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany.

Authors:  D L Bailey; G Antoch; P Bartenstein; H Barthel; A J Beer; S Bisdas; D A Bluemke; R Boellaard; C D Claussen; C Franzius; M Hacker; H Hricak; C la Fougère; B Gückel; S G Nekolla; B J Pichler; S Purz; H H Quick; O Sabri; B Sattler; J Schäfer; H Schmidt; J van den Hoff; S Voss; W Weber; H F Wehrl; T Beyer
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

Review 4.  Imaging features of extranodal involvement in paediatric Hodgkin lymphoma.

Authors:  Suzanne Spijkers; Annemieke S Littooij; Paul D Humphries; Marnix G E H Lam; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2018-12-05

Review 5.  Whole-body magnetic resonance imaging in children - how and why? A systematic review.

Authors:  Pia Zadig; Elisabeth von Brandis; Regina Küfner Lein; Karen Rosendahl; Derk Avenarius; Lil-Sofie Ording Müller
Journal:  Pediatr Radiol       Date:  2020-06-25

6.  Whole-Body MRI Is an Effective Imaging Modality for Hematological Malignancy Treatment Response Assessment: A Systematic Review and Meta-Analysis.

Authors:  Guisen Lin; Xiaodan Zong; Yaowen Li; Weiting Tan; Weisheng Sun; Siqi Zhang; Yungen Gan; Hongwu Zeng
Journal:  Front Oncol       Date:  2022-02-18       Impact factor: 6.244

Review 7.  Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review.

Authors:  A M Smets; E E Deurloo; T J E Slager; J Stoker; S Bipat
Journal:  Pediatr Radiol       Date:  2017-11-18

8.  Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the Oncology Task Force of the ESPR.

Authors:  Jürgen F Schäfer; Claudio Granata; Thekla von Kalle; Martin Kyncl; Annemieke S Littooij; Pier Luigi Di Paolo; Irmina Sefic Pasic; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2020-05-28

Review 9.  Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma.

Authors:  Domenico Albano; Giuseppe Micci; Caterina Patti; Federico Midiri; Silvia Albano; Giuseppe Lo Re; Emanuele Grassedonio; Ludovico La Grutta; Roberto Lagalla; Massimo Galia
Journal:  Diagnostics (Basel)       Date:  2021-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.